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ABSTRACT
Background and Purpose: Individuals who have experienced a pyramidal cerebrovascular
accident (pCVA) often exhibit impairments to volitional control of corresponding motor tasks.
Promising effects in motor response, post-application of transcranial direct current stimulation
(tDCS), have been reported in studies on individuals with the ability to achieve independent gait
for 20 minutes. These studies mainly examined the effects of combined tDCS with locomotor
training on lower extremity function among higher functioning individuals post-stroke. The
purpose of this study was to determine the effect of tDCS among individuals post-stroke who
may not have independent ambulatory capabilities, focusing on motor response and less
demanding outcomes. The results of this study will extend knowledge on tDCS effects among
lower functioning individuals post-CVA.
Methods: Four individuals with chronic stroke (2.38 ± 0.63 years) randomly received either
cathodal stimulation or a sham treatment to their non-lesioned hemisphere. Transcranial
magnetic stimulation (TMS) was used in order identify the tibialis anterior hotspot in the motor
cortex of their lesioned hemisphere such that we were able to assess and reassess the effects of
tDCS at the same hotspot location. Fourteen days later, subjects attended a second session where
they received the intervention that they did not receive in the first session (either sham or
cathodal tDCS). Lower extremity (LE) function was evaluated by comparing pre and post
intervention Timed Up and Go (TUG) scores, as well as Step Length, Stride Length, Stride
Width, Stance Time, Swing Time, Gait Velocity, Ambulation Time, and Cadence. Motor
response was evaluated by comparing pre and post intervention Motor Evoked Potential (MEP)
values.
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Results: There was a statistically significant change in the MEP value measured before and after
cathodal tDCS compared to sham (p = 0.037 < 0.05). There was no statistically significant
difference when comparing tDCS to sham interventions for: resting motor threshold maximum
stimulator output (rMT MSO%), TUG, Step Length, Stride Length, Stride Width, Stance Time,
Swing Time, Gait Velocity, Ambulation Time, and Cadence.
Discussion: For those who are living post-stroke, the application of cathodal tDCS may provide
a relative increase in cortical excitability of the ipsilesional hemisphere. Future tDCS research
should incorporate functional interventions to see if they can promote lasting effects.
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INTRODUCTION
Stroke is a brain lesion that often affects neuromuscular control, impairing the ability of
the brain to generate and transmit motor signals from the motor cortex, through the corticospinal
circuitry, to the intended muscles16. In a non-impaired nervous system, this particular descending
group of nerves from the motor cortex carries the signals for voluntary movement of the
peripheral muscles12. For those with a stroke lesion, the signals are disrupted, and voluntary
motor control is impaired. One barrier to recovery stems from the imbalance of cortical
excitability between the two brain hemispheres, with the lesioned hemisphere having decreased
excitability compared to the non-lesioned hemisphere. This imbalance of cortical excitability is
associated with functional impairments14.
A key concept in the rehabilitation of brain injuries is neuroplasticity, which can be
described as the brain’s ability to adapt and create new neuronal connections in response to
injury14. Progressively challenging a patient’s fine and gross motor control of muscles on their
affected side leverages these neuroplasticity principles. This type of training helps stimulate the
brain to reorganize and improve neuronal connections, and thereby improve transmission of
motor signals6. While these conventional treatments can provide improvements in motor control
for patients post-stroke, there has been recent research examining the benefits of supplementing
treatments with neuromodulation5, 9,11.
Neuromodulation consists of either invasive or noninvasive stimulation of the nervous
system through electrical or chemical approaches23. Modulating cortical excitability using noninvasive neuromodulation techniques has been associated with improved motor performance,
such as walking, in neurologically impaired individuals5. Modulation of cortical excitability can
be performed using either cathodal or anodal transcranial direct current stimulation (tDCS).
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tDCS is a form non-invasive electrical stimulation in which low-intensity electrical stimulation is
applied to a targeted area of the brain in order to elicit neuronal responses in the distal motor
units of the corticospinal tract. Single pulse transcranial magnetic stimulation (TMS) is another
form of noninvasive brain stimulation that can be used in conjunction with tDCS as a tool to
excite the corticospinal tract and elicit a motor evoked potential (MEP) of a targeted muscle24.
Using a device such as TMS compared to participant volitional contraction of the tibialis anterior
muscle allows the researchers to apply a stimulus that is of proportionately equal intensity
amongst all participants.
When applied to the contralesional hemisphere (the hemisphere that does not contain a
lesion), cathodal tDCS has been shown to have an inhibitory effect on motor excitability and is
best used on the contralesional hemisphere in order to decrease interhemispheric inhibition,
resulting in a relative increase in excitability in the affected hemisphere4, 9,11. In contrast, anodal
tDCS applied to the ipsilesional hemisphere (the hemisphere that contains the lesion) has been
shown to have an excitatory effect on motor excitability5. Emerging research using anodal
stimulation is suggestive that it is best utilized over the ipsilesional hemisphere in order to
increase that hemisphere’s ability to transmit motor signals from the cortex to the intended
peripheral muscle by increasing cortical excitability7, 9. This modulation of excitability allows for
a restoration of balance between the two hemispheres and has led to functional improvement20, 26.
When applied individually, anodal and cathodal tDCS have been shown to change
corticomotor excitability in resting subjects. The study by Fregni et al demonstrated an
improvement in hand motor function after the application of cathodal tDCS (applied to the
unaffected motor cortex) and anodal tDCS (applied to the affected motor cortex)9. This effect has
been observed in studies examining both upper and lower extremities18. When paired with a
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functional task such as walking on a treadmill, anodal and cathodal tDCS facilitates transient
increases in lower extremity extensor force and fine motor control within a single session6.
Functional outcomes and corticomotor excitability are greater when tDCS and functional training
are used together compared to anodal or cathodal tDCS alone11.
Previous studies examining tDCS combined with locomotor training have been limited to
patients who could walk continuously for 20 minutes at a time, or without an assistive device,
but these high functioning individuals are not representative of the entire stroke community5.
Many individuals with chronic stroke are limited in activities such as ambulation due to muscle
impairments, requiring greater energy expenditure in performance. Therefore, many of these
patients don’t have the endurance to ambulate for 20 minutes at a time. The purpose of our study
was to test the effect of cathodal tDCS on lower functioning individuals, with a protocol
requiring minimal walking, to determine the potential benefit to this population.

Aim 1: To determine the effects of cathodal tDCS over contralesional motor cortex on the
corticospinal excitability of paretic tibialis anterior (TA).
Hypothesis 1: Cathodal tDCS over the contralesional motor cortex will result in increased
excitability of ipsilesional cortex as measured by MEP of the paretic tibialis anterior muscle.
Aim 2: To examine the functional outcomes associated with inhibition of contralesional motor
cortex using the Timed-Up and Go (TUG) test, and gait variables (stride length, stride width,
stance time, swing time, velocity, ambulation time, and cadence).
Hypothesis 2: Cathodal tDCS over the contralesional motor cortex will improve functional
outcomes in people post stroke, specifically TUG and gait variables during ambulation.
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METHODS
Subjects
A sample of 14 individuals was calculated in order to have 95% power at an α value of 0.05 for a
two-sided paired t-test. Inclusion criteria included diagnosis of a cortical and/or subcortical
lesion and ability to perform a TUG test with or without us of an assistive device. Exclusion
criteria included contraindications to TMS or tDCS (metallic implants, history of seizure, and
use of medications known to alter central nervous system excitability), those confined to a
wheelchair, and anyone under the age of 18 years29. The protocol was approved by UNLV's
Institutional Review Board.
Instrumentation
A Magstim 200 stimulation (Magstim,UK) via a double cone coil was used to apply
TMS. A stereotactic image guidance system (Brainsight, Rogue Research Ic) was used to guide
the site of TMS application. tDCS was delivered through a constant current stimulator via an 8
cm2 oblong saline-soaked sponge cathode placed over the non-lesioned primary motor cortex
(M1) for the leg. A carbonized reference anode was placed on the forehead above the
contralateral orbit. Surface electromyography (EMG) (Bagnoli, Delsys Inc., Natick, MA) was
used to measure the muscle activity from the tibialis anterior and soleus muscles of the affected
limb. The SIGNAL (Cambridge Electronic Design Limited, UK) computer program was used to
collect numerical data after each TMS pulse was applied. The Zeno Mat (ProtoKinetics LLC,
PA), a walkway gait analysis mat, in combination with its ProtoKinetics Movement Analysis
Software (PKMAS), was used to assess gait function by measuring stride length, stride width,
stance time, swing time, velocity, ambulation time, and cadence. The Fugl-Meyer Assessment
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was performed once with each participant, which is an assessment tool used specifically for
individuals post stroke to determine motor and sensory function, balance, joint range of motion,
and joint pain10. The maximum score for the motor function portion of the LE Fugl-Meyer is 34,
indicating no impairment in motor function. The Timed Up and Go test (TUG) was also
administered in order to determine lower extremity functional mobility by having participants
ambulate a self paced 3 meters before and after each treatment session21. Many individuals who
have suffered from a stroke suffer from gait deficits that greatly reduce their ambulation speed,
increasing their risk for falls and diminishing their safety. The TUG is a useful outcome measure
to examine a participant’s functional mobility in a community setting and will be useful in
assessing if application of cathodal tDCS will improve participant ambulation and transfer
speed27.
Procedure
Participants came to the research lab where informed consent was obtained. Subjects then
signed a screening form, which detailed the inclusion and exclusion criteria to the study. Data
collection occurred on two separate days with at least 14 days between the two sessions. Sessions
were scheduled for approximately the same time of day and we requested that participants
followed similar routines on both days. On the first day of data collection, the participants
performed two different tests: the lower extremity Fugl-Meyer, and the TUG performed on the
Zenomat, where gait parameters will also be collected for time conservation. Although the TUG
and the Zenomat assess different variables, the TUG will be performed on the Zenomat in order
to maximize the number of variables that will be measured in a period of time, therefore
decreasing the amount of time the participant spends with the research team, keeping in mind
participant consideration and comfort.
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Next, with the participant standing, the skin above the bellies of the tibialis anterior and
soleus affected by the stroke was shaved, cleaned, and exfoliated with rubbing alcohol swabs.
Shaved areas were limited to twice the size of the electrode. The EMG sensors were then placed
on the prepared skin [Figures 1 & 3], and the ground electrode was placed over the lateral
malleolus. If the participant was able to volitionally contract the tibialis anterior muscle, they
were asked to perform an isometric contraction of the tibialis anterior, lifting the toes into one of
the researcher’s hand, and the researcher would palpate the muscle belly for electrode placement.
For the soleus, the participant would perform a concentric contraction by standing on their toes,
and the researcher would feel for the lateral gastrocnemius muscle head. Keeping the
researcher’s fingers just distal to the head, the participant would then bend their knee and point
their toes into the floor, and the researcher would find the bulk of the belly just distal and lateral
head of the gastrocnemius. The same researcher performed electrode placement each session.
If there was difficulty finding the subject’s muscle bellies, the tibialis anterior was instead
found by creating an imaginary line between the ipsilateral tibial tuberosity and the
intermalleolar line (referred to as the anatomical landmark frame, or ALF), and then placing the
electrode at 20% of the ALF, just distal to the tibial tuberosity. For the soleus, the ALF was
created between the medial side of the Achilles tendon insertion and the head of the fibula. The
electrode was placed just proximal of the insertion of the Achilles at about 30%. Pictures of the
sensor locations were taken to ensure consistent placement across sessions.
The participant was then seated in a chair with the affected leg supported and strapped
into a footplate to keep his or her foot in a neutral dorsiflexed position. One of the researchers
placed a band around the participant’s head that contained a marker that is detected by a camera
system that detects 3D space. The Brainsight Neuronavigation System (Rogue Research Inc) was
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used to determine the brain “hotspot” which is the region of the motor cortex that consistently
elicits the largest MEP of the targeted tibialis anterior muscle when TMS is applied23. The
Brainsight Neuronavigation System provides a human brain template, created from the average
of 25 different brain MRI scans. In combination with the template, 3D markers [Figure 6] were
placed near the participant’s skull. A camera [Figure 4] was used to detect the markers in space
in order to create a 3D model brain similar in size and shape to the subject’s brain.

Figure 1.TA

Figure 4. Camera

Figure 2. Side view

Figure 3. Soleus

Figure 5. Pointer
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Figure 6. 3D Markers

A pointer [Figure 5] was used in combination with the camera to identify five key areas
on the subject’s skin: one over the nasion, one on the lateral portion of each orbit, and one
antero-superior to the tragus of each ear. Then, a series of 30+ measurements were taken to
establish accurate dimensions of the subject’s skull circumference. These measurements record
the most lateral, most superior, most anterior, and most posterior portions of the cranium to
obtain an accurate representation of the subject’s skull in 3D space that was reconstructed and
used as our model on the Brainsight software.
After the model of the participant’s brain was generated, the suprathreshold Machine
Simulated Output (MSO) value of the affected tibialis anterior muscle was found. The
suprathreshold is considered to be the minimum stimulus required to obtain a MEP with > 50
mV peak to peak amplitude over several attempts. The MSO is the output value indicated on the
TMS device. This number can be adjusted up and down to identify the intensity required to
confirm the suprathreshold. In order to find the suprathreshold MSO, the location of M1 was
estimated by identifying a virtual line of connection from the superior aspect of the skull to the
tragus of the ear on the side of the affected hemisphere. This area was confirmed by comparing
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the Brainsight grid of the M1 to the target representing the TMS double coil. A series of TMS
pulses at varying MSO values were given until the EMG reading on the SIGNAL software
(Cambridge Electronic Design Limited, England) demonstrated consistent motor evoked
potentials (MEPs) of the affected tibialis anterior and soleus greater than 0.05 mV within the M1.
Once the suprathreshold MSO was determined, an 8x4 grid constructed by Brainsight
was placed over the affected motor cortex of the model on the software, indicating to the
researchers the location of each spot for TMS stimulation on the actual brain. The grid was
constructed of 32 different locations, and using the TMS coil, each spot was stimulated while the
corresponding MEP amplitudes were recorded using SIGNAL. The coil contained a 3D marker
that allowed the Brainsight camera to determine its location in comparison to the participant’s
brain, and this allowed for accurate stimulation of each spot in the grid. The hotspot was
determined by the location that elicited the highest MEP amplitude at the given supramaximal
stimulus level.
The hotspot was then used to determine the resting motor threshold (rMT) using the
Parameter Estimation by Sequential Testing (PEST) procedure provided within the software
TMS Motor Threshold Assessment Tool (TMS MTAT 2.0) 3. This also involves using SIGNAL
software to observe for an EMG reading greater than 0.05 mV. PEST generated the MSO of the
rMT through the use of an algorithm, which refined the minimum TMS output percentage that
was strong enough to elicit a reading greater than 0.05 mV.
Once the above steps were completed, a series of TMS pulses at varying MSOs were
applied to the hotspot until the EMG reading on the SIGNAL software demonstrated consistent
MEPs of the affected tibialis anterior that averaged 0.1 mV after ten pulses. In order to apply the
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minimum number of pulses and maintain subject comfort, the MSO of the suprathreshold
previously obtained was increased by increments of 2%, until the desired level was achieved.
Participants received either cathodal tDCS or sham treatment for 20 minutes and in the
second session received the other, such that at the end of their second session they had
experienced both sham and tDCS. The treatment that they received during the first session was
determined randomly, and they received the other treatment during their second session. Only
one of the researchers knew which treatment the patient received and that researcher was not
involved in data collection. The remaining personnel involved were blinded to the intervention
group.
tDCS strength was set at 0.06 mA/cm2. The electrical field was oriented with the
stimulation electrode at the M1 leg area of the affected cortex and the reference electrode placed
on the contralateral orbit20. The participant had his or her foot strapped with Velcro to a force
plate set at 0˚ neutral dorsiflexion. With visual feedback, the participant activated the TA muscle
at 20% maximal TA EMG activity at a consistent rate isometrically (2 second contraction, 2
second relax), set by a metronome at 30 Hz throughout the 20 minutes of tDCS application. After
20 minutes, the tDCS or sham treatment was removed and we assessed the post-test MEP values
at 120% rMT.
The participant performed the TUG on the Zenomat as they did at the beginning of the
session, starting with using PEST to determine the MSO of the rMT. However, for the second
outcome measure regarding the MSO MEP, we utilized the same MSO that produced and
average of 0.1 mV previously and stimulated the person’s brain only ten times to find the new
average of the ten readings. Then, the participant was disconnected from the EMGs and was
required to perform a second TUG test on the Zenomat.
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Data Analysis
IBM SPSS for Windows Version 24.0 was used to perform all statistical analyses.
Descriptive statistics included mean and standard deviation of each variable were calculated
based on time (pre/post intervention) and intervention type (cathodal tDCS/sham). A 2 x 2
repeated measures ANOVA was used to determine association between the intervention type,
time, and the interaction between intervention type and time. Appropriate post-hoc analysis was
then used to determine differences in pairwise comparisons. Statistical significance was defined
as P < 0.05.
RESULTS

Four participants with chronic post-stroke hemiparesis completed the study. Participant
characteristics are presented in Table 1.
For the MEP, there was no statistically significant interaction found for time and
condition (F(1,3)=0.810, p=0.43). There was no statistically significant difference found for
condition (F(1, 3)=1.48, p=0.31). There was a statistically significant difference found for time
(F(1, 3)=12.79, p=0.04). Simple main effect analysis using paired samples T-Test showed that
following cathodal stimulation, MEP amplitudes were higher (0.34mV±0.20) compared to before
stimulation (0.24±0.12) (p=0.02). In contrast, following sham stimulation, MEP amplitude did
not change (0.24±0.43) compared to before stimulation (0.25±0.16) (p=0.74).
For the rMT, TUG, Step Length, Stride Length, Stride Width, Stance Time, Swing Time,
Gait Velocity, Ambulation Time, and Cadence, the 2 way ANOVA revealed no significant
interaction between condition and time and there were no statistically significant differences
found for condition or for time.
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Table 1: Subject Demographics
Age (yr)

63.50+6.75

Lesion Side (L|R)

4|0

Time Post Stroke (yr)

2.38+0.63

LE F-M Score

31.75+2.38

Table 2: Change in TMS and Gait Variables and Effect Significance
of that Change based on Intervention Groups
Variable
Type
TMS

Variable
rMT
MSO%

MEP (mV)

Gait
Analysis

TUG (sec)

Step Length
(cm)

Stride
Length (cm)

Intervention

Pre
Intervention

Post
Intervention

Difference

Effect

Effect
Significance

tDCS

50.25+9.60

51.75+9.18

1.5

tDCS:

0.83

Sham

51.00+10.10

49.75+9.71

-1.25

Time:

0.95

Time x
tDCS:

0.151

tDCS

0.240+0.119

0.341+0.204

0.101

tDCS:

0.311

Sham

0.254+0.163

0.241+0.430

-0.013

Time:

0.037

Time x
tDCS:

0.434

tDCS

10.93+1.77

10.85+1.65

-0.08

tDCS:

0.412

Sham

12.26+3.42

11.33+2.05

-0.93

Time:

0.324

Time x
tDCS:

0.289

tDCS

50.65+4.82

52.74+3.97

2.09

tDCS:

0.328

Sham

49.07+7.21

49.08+5.30

0.01

Time:

0.406

Time x
tDCS:

0.38

tDCS:

0.437

tDCS

102.68+10.30

102.56+8.91

12

-0.12

Sham

Stride
Width (cm)

96.81+15.51

99.08+12.01

2.27

Time:

0.346

Time x
tDCS:

0.532

tDCS

12.13+4.60

12.97+3.07

0.84

tDCS:

0.879

Sham

12.63+4.99

12.85+3.34

0.22

Time:

0.583

Time x
tDCS:

0.747

Stance Time tDCS
(sec)

0.864+0.097

0.854+0.066

0.01

tDCS:

0.648

Sham

0.872+0.124

0.824+0.068

-0.048

Time:

0.374

Time x
tDCS:

0.528

Swing Time
(sec)

Gait
Velocity
(cm/sec)

Ambulation
Time (sec)

Cadence
(steps/min)

tDCS

0.469+0.138

0.472+0.117

-0.042

tDCS:

0.734

Sham

0.428+0.089

0.447+0.102

0.019

Time:

0.591

Time x
tDCS:

0.21

tDCS

76.01+7.52

82.15+11.66

6.14

tDCS:

0.558

Sham

75.18+19.59

77.04+13.03

1.86

Time:

0.261

Time x
tDCS:

0.634

tDCS

6.89+1.28

6.30+1.01

-0.59

tDCS:

0.278

Sham

7.51+1.53

7.13+1.53

-0.38

Time:

0.1

Time x
tDCS:

0.755

tDCS

90.35+13.16

97.13+11.45

6.78

tDCS:

0.979

Sham

93.07+12.02

94.48+9.38

1.41

Time:

0.21

Time x
tDCS:

0.461
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Table 3: MEP Change Pre and Post Intervention
Pre-Intervention MEP (mV)

Post-Intervention MEP (mV)

P value

tDCS

0.240 ± 0.119

0.341 ± 0.204

0.016

Sham

0.254 ± 0.163

0.241 ± 0.430

0.735

*Using paired sample T test

Figure 7. Comparison of MEP value prior
to and following tDCS intervention
0.6

MEP Value (mV)

0.5
P value= 0.016

0.4
0.3
0.2
0.1

0.341

0.24

0
Pre tDCS

Post tDCS
DISCUSSION

We found that the MEP amplitude of the affected tibialis anterior muscle was
significantly improved in those who received cathodal tDCS intervention, while there was no
improvement for those who had the sham treatment. This indicates a relative increase in
excitation of the corticospinal tract of the lesioned side due to inhibition of the contralesional
hemisphere. The increased electrical conductivity to the affected tibialis anterior has positive
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implications for future rehabilitation of an individual chronic post-stroke. Individuals with
chronic stroke have passed the traditional “therapeutic window” in which neuroplasticity
training is known to be most fruitful14. By inhibiting the contralesional hemisphere with
cathodal tDCS there is an opportunity for the individual to perform rehabilitative interventions
focused on increasing strength, endurance, and coordination in lower extremity musculature via
changes in the corticospinal tract excitation8. This process allows the ipsilesional hemisphere to
regain greater influence over the ipsilateral corticospinal tracts4, 6. This in turn can allow the
ipsilesional hemisphere to become effectively stronger and more influential regarding the
control of signals through the corticospinal tract due to increased communication from the
affected motor region in the hemisphere to the tibialis anterior muscle and therefore increased
rehabilitation potential6, 11.
Although not statistically significant, there was a trend toward increased gait velocity in
subjects that got tDCS treatment, although step length, stride length, stride width, and cadence
did not seem to be affected. However, we cannot be sure if the application of cathodal tDCS is
responsible for the trending increase in gait velocity, or if there was a learning effect from
repeatedly performing the TUG. Despite, the TUG being a quick and simple test, reliable for
quantifying change over time in older adult populations, a learning effect is still important to
consider21.
There are several possible explanations for why we did not find significant associations
between our outcomes and tDCS application. One is that we were unable to recruit 14
participants, and in fact only recruited 4, leaving the study underpowered. It is likely that we
were unable to detect actual effects given this small sample. Another reason may be due to
testing cathodal versus anodal tDCS on the lower extremities. A majority of studies look at the
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effect of cathodal tDCS on the upper extremities or focus more on the effects of anodal tDCS
stimulation over the affected hemisphere. Jeffery et al. discussed how anodal stimulation has
depolarizing effects, allowing for greater corticospinal tract conductivity, whereas cathodal tDCS
has a hyperpolarizing affect. They noted that hyperpolarizing stimulation of the lower extremity
compared to the upper extremity with equivalent currents had a minimal effect on the amplitude
of measured MEPs recorded both at rest and during contraction of the tibialis anterior muscle13.
This suggests that it is more difficult to suppress the excitability of the leg motor cortex
compared to the hand motor cortex with cathodal tDCS due to fewer available inhibitory circuits
compared to the hand motor cortex. Although we were not trying to suppress the excitability of
the involved hemisphere, it is still possible that it makes suppressing the uninvolved hemisphere
more difficult as well, making a large impact less possible and reducing the influence from the
healthy cortex.
Although our goal was to recruit lower functioning patients, our participants were rather
high functioning, even after having experienced a stroke. Several of our patients exercised
regularly and were self-reported community ambulators. Our high functioning sample does not
allow us to determine if step length, stride length, stride width, or cadence were improved by
tDCS because they were not impaired to begin with. Chang et al tested anodal tDCS effects to
see if application could not only increase cortical excitability but also lower limb motor function.
They discovered that although there was some recovery of lower limb weakness with application
of anodal tDCS, the amount of recovery was not enough to improve function in standing or gait5.
However, they suggested that tDCS could be used as an adjuvant therapeutic modality to assist
with improving lower limb motor function. We had similar results as Basanti et al, who
performed a systematic review on the effects of anodal tDCS and motor function in healthy
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individuals and those affected by stroke. Their review concluded that the evidence supports
induced MEP with TMS and a tDCS intervention increases peak-to-peak MEP amplitude,
indicating an increase in corticospinal tract excitation in both healthy and individuals affected by
stroke. However, they did not see evidence for significant effects in motor function
improvements for people with or without stroke2. Our study suggests that there may be a
particular level of functional mobility deficits at which tDCS has its greatest impact on
rehabilitation potential. Future studies should examine whether or not a specific level of
functional mobility exists at which improvement with tDCS can be observed.
It is also important to note that another potential increase in MEP amplitude could have
been due to performing isometric exercise during the session. EMG signals, and therefore MEP
amplitudes, increase during sustained sub-maximal voluntary contraction, especially towards the
end of a contraction25. Therefore, we can’t determine if our participants increase in MEP was
created solely by the application of tDCS, if their isometric dorsiflexion activity while receiving
the tDCS, or a combination affected their MEP change.
Interestingly enough, many participants said they felt better the day after receiving
treatment. Three of our subjects stated that they felt that they could walk better the next day and
for a few days following their participation. We did not take measurements in the days following
treatment so we cannot know the extent or reality of these reports. Additionally, there is high
potential for placebo to account for the subjects’ experience. It may be beneficial in future
studies to collect data immediately after and then 24 hours after tDCS application. Another
option for future studies would be to include patient reported outcomes. Chang et al. had
measured the effects of anodal stimulation 24 hours post application and found that corticospinal
excitation had indeed increased compared to sham. This resulted in statistically significant
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increases in Fugl-Meyer scores as well as scores for the Lower Limb Motricity Index. They also
discovered a trend for greater changes within the Functional Ambulatory Category with those
who received anodal stimulation versus the sham5. Additionally, future work should consider the
effects of tDCS on MEP with multiple applications as larger increases may be seen with more
consistent application due to a cumulative effect1.
Another implication for future research would be to examine the effects of cathodal tDCS
on multiple lower extremity muscles. Our study only looked at the effects of cathodal tDCS on
the tibialis anterior muscle, yet we looked at complete gait cycle outcomes. Other important
muscles responsible for smooth gait, such as the quadriceps, gastrocnemius, and hamstrings,
could be impacted by the use of tDCS28. Seeing that the MEP increased in the corticospinal tracts
for tibialis anterior, it is likely that the corticospinal tracts of other lower extremity muscles were
also positively affected. A study by Tanaka et al provides evidence that tDCS can be used to
improve force produced by a paretic quadricep, therefore increasing the participant’s ability to
extend their knee28. Future research should consider therapeutic interventions to multiple
muscles of the leg and other impairments, such as lack of hip extension or knee extension
strength.
CONCLUSION
This study examined the effect of cathodal tDCS over the contralesional M1 area
responsible for the tibialis anterior. Our subjects experienced a statistically significant increase in
MEP when they received tDCS and no change when they received sham. However, there was no
change in gait or TUG. Future studies should examine the effect of cathodal tDCS on individuals
post-stroke with a variety of functional abilities, consider other muscles, and examine effects
over 1-4 days.
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